STOP 2030: TOWARDS THE INTERRUPTION OF TRANSMISSION OF SOIL-TRANSMITTED HELMINTHS: PROMOTING IMPLEMENTATION OF RESEARCH RESULTS OF A FIXED-DOSE COMBINATION OF CO-FORMULATED IVERMECTIN AND ALBENDAZOLE

Informazioni relative al progetto

STOP2030

ID dell’accordo di sovvenzione: 101103089

DOI

10.3030/101103089

Data della firma CE 7 Marzo 2023

Data di avvio 1 Luglio 2023

Data di completamento 30 Giugno 2027

Finanziato da

• Health

Costo totale

€ 5 046 435,75

Contributo UE

€ 3 553 502,25

Coordinato da

LABORATORIOS LICONSA SA
Spain

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (9)

Communication Plan

Internal Communication plan to define the internal communication channels and tools to promote the exchange of ideas and the sharing of information among the Consortium's members.

Clinical data management plan (cDMP)

Description of the data management life cycle for the data to be collected, processed and/or generated by STOP2030 project

Registration number of clinical study

Trial registration in public access trial repositories

Clinical monitoring plan

Plan establishing the guidelines for conducting monitoring visits and timelines

Terms of reference for project committees

Define the different project Committees, scope, frequency and participant

Genomic protocol

Protocol for reporting on genomic data generation and submission to open access repositories, standardisation of code description and availability

Risk management record (Y1)

List of potential risk and mitigation plans to either avoid or minimize

Data analysis and interpretation

Analyse and interpretate data in collaboration with Consortium members

Formative study on Acceptability & Feasibility completed

Protocol for the formative study on acceptability and feasibility to be implemented in Ghana and Kenya

Websites, patent fillings, videos etc. (1)

Launched Project - WEBSITE

Project Website and as per good practices, all work packages leads will be listed.

Pubblicazioni

Peer reviewed articles (3)

Implications of global health funding patterns for implementation of a novel soil-transmitted helminth and lymphatic filariasis medicine: Ivermectin/albendazole fixed-dose combination

Autori: Israel Wuresah, Alan Brooks, Nikita Kubal, Marina Gold, Alejandro Krolewiecki, Julie Jacobson
Pubblicato in: PLOS Neglected Tropical Diseases, Numero 20, 2026, ISSN 1935-2735
Editore: Public Library of Science (PLoS)
DOI: 10.1371/JOURNAL.PNTD.0014458

Fixed-dose ivermectin for Mass Drug Administration: Is it time to leave the dose pole behind? Insights from an Individual Participant Data Meta-Analysis

Autori: Adriana Echazu, Daniela Bonanno, Pedro Emanuel Fleitas, Julie Jacobson, Gabriela Matamoros, Charles Mwandawiro, Wendemagegn Enbiale, Áuria de Jesus, Alan Brooks, Alejandro Javier Krolewiecki
Pubblicato in: PLOS Neglected Tropical Diseases, Numero 19, 2025, ISSN 1935-2735
Editore: Public Library of Science (PLoS)
DOI: 10.1371/JOURNAL.PNTD.0013059

Cost-effectiveness of soil-transmitted helminthiasis intervention programmes: A scoping review

Autori: Michael Odhiambo, Israel Wuresah, Geofrey Chepchieng, Nikita Kubal, Alejandro Krolewiecki, Charles Mwandawiro, Alan Brooks, Collins Okoyo
Pubblicato in: PLOS Neglected Tropical Diseases, Numero 20, 2026, ISSN 1935-2735
Editore: Public Library of Science (PLoS)
DOI: 10.1371/JOURNAL.PNTD.0014317